研究单位：[1]Tongji Hospital[2]Hubei Cancer Hospital[3]Qilu Hospital of Shandong University[4]Wuhan Central Hospital[5]Xiangyang Central Hospital[6]The First People's Hospital of Jingzhou[7]The First Affiliated Hospital with Nanjing Medical University
研究目的：
Breast cancer remains the most common cancer in women worldwide. Early diagnosis can greatly improve the prognosis. To date, imaging examination is still the most important diagnostic and grading tool for breast cancer. Semaphorin4C (SEMA4C) has previously been identified as a highly expressed protein by breast cancer-associated lymphatic endothelial cells (LECs). The study is undertaken to evaluate the diagnostic efficiency of SEMA4C.
